DarioHealth expands GLP-1 solution client base with new employer contract

DarioHealth announced a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in Q3. The employer, a provider of environmental services, selected Dario’s cardiometabolic suite to address multiple health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including integrated support for those employees taking a GLP-1 medication.